Asio Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Asio Capital's BMY Position: Q2 2026 in Review
Asio Capital increased its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2026, buying an estimated $182K and bringing the position to 56,189 shares worth $3.24M. The position accounts for 0.41% of the portfolio, ranked #70.
Asio Capital first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.83M in Q2 2021. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Asio Capital held 56,189 shares of Bristol-Myers Squibb worth $3.24M as of Q2 2026.
- Asio Capital bought 3,172 Bristol-Myers Squibb shares in Q2 2026, an estimated $182K.
- Bristol-Myers Squibb made up 0.41% of Asio Capital's portfolio in Q2 2026, its #70 holding.
- Asio Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- Asio Capital's Bristol-Myers Squibb position peaked at $3.83M in Q2 2021.
- 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Asio Capital's 13F filing for Q2 2026, filed 17 Jul 2026.